Accelerating Drug Discovery

Lupus Therapeutics was established to advance lupus clinical research by finding more effective and safer treatments for people living with lupus. In well over half a century only one new drug has been approved to treat this disease; this is not good enough. We are committed to finding and illuminating promising new treatment opportunities, and ultimately delivering them to lupus patients in just years, not decades.

This is an aspirational investment that we invite every stakeholder in the lupus community to take part in—patients, doctors, researchers and industry.

Lupus Clinical Investigators Network (LuCIN) Site Locations

LuCIN is an academic-based clinical trials network comprised of some of the most prestigious medical research centers and experienced lupus physician-scientists throughout North America.

Click on State or Province to zoom. Click on the site location for more information.

Watch this video to learn more about Lupus Therapeutics and
find out why it will bring us better treatments for lupus faster.

Lupus Therapeutics News

Two Lupus Therapeutics Studies...

November 12, 2019 Two positive clinical studies presented at the 2019 ACR/ARP Annual Meeting were conducted through the Lupus Clinical Investigators Network...

Read More

10 Lupus Therapeutics studies...

      TAK-079 A Study to Evaluate the Safety of TAK-079 PAISLEY-SLE A Phase II study to evaluate a novel, oral...

Read More

Welcoming Daniel J. Wallace,...

The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel J. Wallace, MD joins as a new member...

Read More

Contact Us

Lupus Therapeutics mission is to accelerate drug discovery and diagnostic innovation for all patients living with lupus. If you would like to learn more please contact us:

Learn more about ongoing clinical trials being conducted within LuCIN